Profile data is unavailable for this security.
About the company
Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its Technegas product is a broad-spectrum diagnostic lung imaging technology for visualization of pulmonary ventilation and lung function. It includes the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. Company distributes its products in approximately 65 countries.
- Revenue in AUD (TTM)29.68m
- Net income in AUD-13.38m
- Incorporated2005
- Employees95.00
- LocationCyclopharm LtdUnit 4 / 1 The Crescent, KingsgroveSYDNEY 2208AustraliaAUS
- Phone+61 29541-0411
- Fax+61 29543-0960
- Websitehttps://www.cyclomedica.com/company/cyclopharm/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cleanspace Holdings Ltd | 19.76m | -478.27k | 50.16m | -- | -- | 2.61 | 113.57 | 2.54 | -0.0062 | -0.0062 | 0.2538 | 0.2448 | 0.7372 | 1.95 | 4.94 | -- | -1.78 | -6.87 | -2.07 | -8.29 | 74.76 | 74.57 | -2.42 | -10.49 | 4.46 | -- | 0.1914 | -- | 25.72 | -6.99 | 84.71 | -- | -23.72 | -- |
| Vitasora Health Ltd | 3.71m | -10.11m | 50.17m | 2.00 | -- | 2.90 | -- | 13.54 | -0.0071 | -0.0071 | 0.0027 | 0.0093 | 0.3013 | 0.0106 | 4.17 | -- | -82.17 | -118.94 | -115.44 | -176.54 | 99.19 | 78.72 | -272.73 | -533.63 | 0.6694 | -- | 0.0039 | -- | 256.77 | 10.92 | -41.74 | -- | -- | -- |
| Micro-X Ltd | 13.05m | -13.90m | 58.81m | -- | -- | 7.16 | -- | 4.51 | -0.023 | -0.023 | 0.0214 | 0.0113 | 0.5328 | 0.5665 | 3.51 | -- | -56.71 | -41.13 | -95.63 | -53.72 | 79.05 | 68.51 | -106.45 | -104.84 | 1.13 | -30.40 | 0.464 | -- | -14.25 | 11.56 | -42.29 | -- | -46.10 | -- |
| Singular Health Group Ltd | 702.02k | -6.26m | 67.50m | -- | -- | 4.95 | -- | 96.15 | -0.0258 | -0.0266 | 0.003 | 0.0434 | 0.0848 | -- | 7.39 | -- | -75.64 | -120.64 | -86.15 | -162.51 | -- | -- | -892.01 | -824.18 | -- | -599.39 | 0.00 | -- | -25.77 | 40.56 | -117.55 | -- | -1.59 | -- |
| Compumedics Ltd | 50.83m | -1.27m | 70.92m | 175.00 | -- | 3.14 | 75.93 | 1.40 | -0.0068 | -0.0068 | 0.270 | 0.1129 | 1.07 | 1.64 | 3.91 | 290,451.40 | -2.68 | -2.60 | -6.10 | -4.92 | 54.93 | 52.69 | -2.49 | -2.48 | 0.6456 | 0.6855 | 0.39 | -- | 2.23 | 7.71 | -275.15 | -- | 11.67 | -- |
| Mach7 Technologies Ltd | 34.64m | -6.20m | 83.43m | 90.00 | -- | 1.83 | 80.09 | 2.41 | -0.0259 | -0.0259 | 0.1443 | 0.194 | 0.5048 | -- | 6.07 | -- | -9.04 | -7.68 | -11.51 | -9.10 | 94.24 | 95.77 | -17.90 | -20.36 | -- | -26.29 | 0.024 | -- | 15.42 | 12.93 | 22.19 | -- | 84.49 | -- |
| Vitrafy Life Sciences Ltd | 66.28k | -14.15m | 85.41m | -- | -- | 5.04 | -- | 1,288.58 | -0.1807 | -0.1807 | 0.0008 | 0.3391 | 0.0022 | -- | 0.2465 | -- | -47.44 | -- | -49.60 | -- | -- | -- | -21,351.00 | -- | -- | -- | 0.0158 | -- | 75.17 | -- | -213.76 | -- | -- | -- |
| Optiscan Imaging Ltd | 951.95k | -6.31m | 88.76m | 8.00 | -- | 9.27 | -- | 93.23 | -0.0075 | -0.0075 | 0.0011 | 0.0092 | 0.0727 | 0.257 | 0.5149 | -- | -48.21 | -49.13 | -55.07 | -57.06 | 50.41 | 11.82 | -663.05 | -405.67 | 4.76 | -- | 0.1611 | -- | -17.62 | -4.38 | -4.15 | -- | 35.75 | -- |
| Cyclopharm Limited | 29.68m | -13.38m | 100.11m | 95.00 | -- | 2.56 | -- | 3.37 | -0.1214 | -0.1214 | 0.2694 | 0.3248 | 0.4946 | 0.9306 | 6.28 | 312,380.80 | -22.29 | -15.69 | -27.32 | -18.73 | 61.48 | 67.79 | -45.07 | -31.55 | 1.94 | -- | 0.181 | -- | -0.694 | 14.35 | -180.75 | -- | 15.28 | -- |
| SDI Ltd | 110.38m | 12.16m | 106.38m | 300.00 | 8.75 | 1.04 | 6.25 | 0.9638 | 0.1023 | 0.1023 | 0.9287 | 0.8638 | 0.7833 | 1.45 | 5.43 | -- | 8.63 | 7.81 | 10.31 | 9.29 | 62.85 | 59.86 | 11.02 | 9.06 | 1.62 | 28.73 | 0.1448 | 42.64 | -0.7392 | 10.38 | 16.69 | 23.47 | 13.53 | 12.94 |
| Austco Healthcare Ltd | 81.41m | 5.93m | 118.05m | 174.00 | 19.68 | 2.22 | 13.42 | 1.45 | 0.016 | 0.016 | 0.2197 | 0.1421 | 1.02 | 3.91 | 4.67 | -- | 7.43 | 9.35 | 10.83 | 13.33 | 52.05 | 53.07 | 7.29 | 8.39 | 1.28 | -- | 0.1233 | -- | 39.98 | 19.76 | -16.15 | 18.83 | 25.65 | -- |
| Epiminder Ltd | -100.00bn | -100.00bn | 147.16m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -93.22 | -- | -99.64 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Cyclopharm Ltd's reporting currency: Australian Dollar AUD
28.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Regal Funds Management Pty Ltd.as of 28 Feb 2025 | 12.00m | 10.80% |
| Australian Ethical Investments Ltd. (Investment Management)as of 28 Feb 2025 | 9.87m | 8.88% |
| Investors Mutual Ltd.as of 12 Feb 2026 | 7.07m | 6.36% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 2.16m | 1.94% |
| DFA Australia Ltd.as of 31 Dec 2025 | 74.90k | 0.07% |
More ▼
Data from 30 Sep 2025 - 02 Feb 2026Source: FactSet Research Systems Inc.
